Image

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Exploring new proton therapy for non-cancerous brain tumors.

Recruiting
18 years and older
All
Phase N/A

Study on Proton Therapy for Brain Tumors

This study looks at a special kind of radiation treatment called hypofractionated proton or photon therapy for brain tumors. Here, "hypofractionated" means giving higher doses of radiation in a shorter time. This might help kill more tumor cells and could mean fewer side effects and lower costs. The study wants to see how well this treatment works over three years.

There are two groups in the study:

  • Cohort I: Patients with benign brain tumors receive treatment daily for about 3.5-4 weeks.
  • Cohort II: Patients with certain types of meningiomas get similar treatment also for 3.5-4 weeks.

After treatment, patients will have regular follow-ups.

  • Key Points:
  • The study lasts for about 3.5-4 weeks.
  • Patients need to visit daily, Monday to Friday.
  • The study helps understand treatment effects and quality of life.

To join, you must have a specific type of brain tumor and agree to the treatment. Pregnant women and those who’ve had overlapping radiation therapy before cannot join.

Study details
    Grade I Meningioma
    Grade II Meningioma
    Grade III Meningioma
    Intracranial Neoplasm
    Nerve Sheath Neoplasm
    Pituitary Gland Adenoma
    Schwannoma

NCT04278118

Emory University

28 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.